NorthRock Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
NorthRock Partners's AMGN Position: Q3 2026 in Review
NorthRock Partners reduced its Amgen (AMGN) stake by 24% in Q3 2026, selling an estimated $593K and leaving 4,714 shares worth $1.99M. The position accounts for 0.03% of the portfolio, ranked #224.
NorthRock Partners first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. The position peaked at $3.62M in Q3 2024. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- NorthRock Partners held 4,714 shares of Amgen worth $1.99M as of Q3 2026.
- NorthRock Partners sold 1,489 Amgen shares in Q3 2026, an estimated $593K.
- Amgen made up 0.03% of NorthRock Partners's portfolio in Q3 2026, its #224 holding.
- NorthRock Partners first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
- NorthRock Partners's Amgen position peaked at $3.62M in Q3 2024.
- 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on NorthRock Partners's 13F filing for Q3 2026, filed 13 Nov 2026.